 |
 |

CLINICIAN'S CORNER
Does This Patient Have Ventilator-Associated Pneumonia?
Michael Klompas, MD
JAMA. 2007;297:1583-1593.
Context Ventilator-associated pneumonia (VAP) is a common and serious nosocomial infection. Accurate, timely diagnosis enables affected patients to receive appropriate therapy and avoids mistreatment of patients having other conditions.
Objective To review the published medical literature describing the precision and accuracy of clinical, radiographic, and laboratory data to diagnose bacterial VAP relative to a histological gold standard.
Data Sources English-language articles identified by a structured search strategy using MEDLINE (January 1966-October 31, 2006) and Google Scholar. Additional articles were identified through the reference lists of studies and review papers identified by the search strategy.
Study Selection Included studies described clinical findings associated with VAP in 25 or more patients receiving mechanical ventilation who subsequently underwent pulmonary biopsy or autopsy. Fourteen studies describing clinical findings in 655 patients met inclusion criteria.
Data Extraction Data were abstracted onto a structured form, allowing calculation of the likelihood ratios (LRs) for each sign or combination of findings.
Data Synthesis The presence or absence of fever, abnormal white blood cell count, or purulent pulmonary secretions do not substantively alter the probability of VAP. However, the combination of a new radiographic infiltrate with at least 2 of fever, leukocytosis, or purulent sputum increases the likelihood of VAP (summary LR, 2.8; 95% confidence interval, 0.97-7.9). The absence of a new infiltrate on a plain chest radiograph lowers the likelihood of VAP (summary LR, 0.35; 95% confidence interval, 0.14-0.87). Fewer than 50% neutrophils on cell count analysis of lower pulmonary secretions makes VAP unlikely (LR range, 0.05-0.10).
Conclusions Routine bedside evaluation coupled with radiographic information provides suggestive but not definitive evidence that VAP is present or absent. Given the severity of VAP and the frequency of serious conditions that can mimic VAP, clinicians should be ready to consider additional tests that provide further evidence for VAP or that establish another diagnosis.
Author Affiliations: Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass; and Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston.
CiteULike Connotea Del.icio.us Digg Reddit Technorati
What's this?
RELATED ARTICLE
Ventilator-Associated Pneumonia
Janet M. Torpy, Cassio Lynm, and Richard M. Glass
JAMA. 2007;297(14):1616.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Diagnostic Implications of Soluble Triggering Receptor Expressed on Myeloid Cells-1 in BAL Fluid of Patients With Pulmonary Infiltrates in the ICU
Anand et al.
Chest 2009;135:641-647.
ABSTRACT
| FULL TEXT
VAT vs VAP: Are We Heading Toward Clarity or Confusion?
Dallas and Kollef
Chest 2009;135:252-255.
FULL TEXT
Ventilator-Associated Tracheobronchitis: The Impact of Targeted Antibiotic Therapy on Patient Outcomes
Craven et al.
Chest 2009;135:521-528.
ABSTRACT
| FULL TEXT
Ventilator-Associated Pneumonia The Wrong Quality Measure for Benchmarking
Klompas and Platt
ANN INTERN MED 2007;147:803-805.
ABSTRACT
| FULL TEXT
The GAAP in Quality Measurement and Reporting
Pronovost et al.
JAMA 2007;298:1800-1802.
FULL TEXT
|